EUVIMEDEUVIMED entdecken
Crossref

A novel approach to differentiate prostate cancer from prostatitis in the peripheral zone

Chun-Lei He iD, Ting Yang iD, Meng-Ni Zhang iD, Jin Yao iD, Ling Yang iD

British Journal of Radiology · 2025

DOI: 10.1093/bjr/tqaf186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Chun-Lei He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Hauptthemen laut MEDLINE: Prostatitis, Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Magnetic Resonance Imaging. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To analyse the different imaging manifestations of prostatitis and prostate cancer (PCa), and propose systematic differentiation and validate its diagnostic performance.

Methods

Men with histologically proven prostatitis or PCa who had pretreatment multiparametric MRI and lesions in the peripheral zone were retrospectively identified from January 2018 to May 2022. The images were evaluated by 2 experienced radiologists, and key imaging features for differential diagnosis were summarized and analysed via univariable and multivariable logistic regression. The best differentiating model was generated via refining the original Prostate Imaging Reporting and Data System (PI-RADS) standard (rPI-RADS). Two inexperienced radiologists reevaluated the images according to the PI-RADS and rPI-RADS criteria, then compared.

Results

A total of 315 patients were enrolled in this study, including 181 patients with clinically significant PCa (67.3 ± 7.7 years) and 134 patients with prostatitis (64.8 ± 9.6 years). The differentiated model was based on diffuse distribution, wedge shape, T1 iso-hyperintensity, rim enhancement, and delayed periprostatic enhancement, thus forming the rPI-RADS standard according to these features. Paired comparison study showed that 22 out of 121 (18.2%, P < .001) inflammatory lesions were corrected from PI-RADS category 4-5 to rPI-RADS category 2, and 20 out of 121 (16.5%, P < .001) were corrected from PI-RADS category 4-5 to rPI-RADS category 1-3 by 2 inexperienced radiologists.

Conclusions

The supplementary descriptions of wedge-shaped and diffuse distributed lesions were helpful for inexperienced radiologists. The refined principle of score reduction may reduce false-positive PI-RADS scores for prostatitis. Advances in knowledge A systematic differentiation of PCa from prostatitis was proposed, and validated by inexperienced radiologists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatitisProstatic NeoplasmsMultiparametric Magnetic Resonance ImagingMagnetic Resonance ImagingHumansMaleDiagnosis, DifferentialRetrospective StudiesAgedMiddle AgedProstate

Stichwörter der Autor:innen

magnetic resonance imagingprostate cancerprostate imaging reporting and data systemprostatitis

Autor:innen und Institutionen

  • Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

ORCID-Profile: Chun-Lei He, Ting Yang, Meng-Ni Zhang, Jin Yao, Ling Yang

Zitieren

APA

He, C. L., Yang, T., Zhang, M. N., Yao, J., & Yang, L. (2025). A novel approach to differentiate prostate cancer from prostatitis in the peripheral zone. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf186

Vancouver

He CL, Yang T, Zhang MN, Yao J, Yang L. A novel approach to differentiate prostate cancer from prostatitis in the peripheral zone. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf186

BibTeX
@article{He2025,
  author = {He, Chun-Lei and Yang, Ting and Zhang, Meng-Ni and Yao, Jin and Yang, Ling},
  title = {A novel approach to differentiate prostate cancer from prostatitis in the peripheral zone},
  journal = {British Journal of Radiology},
  year = {2025},
  doi = {10.1093/bjr/tqaf186}
}
Kostenlos starten →